LINDEINDIA

Linde India Limited

Industrial and medical gases and project engineering services

Commodities›Chemicals›Chemicals & Petrochemicals›Industrial Gases

linde.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹6184.50
Market cap
52,762 Cr
Stock P/E
96.6
P/B
12.36
Dividend yield
0.2%
ROE (FY26)
12.9%
ROCE (FY26)
17.5%
Operating margin (FY26)
26.6%
OCF / EBITDA (FY26)
86.4%
OCF / EBITDA (3Y)
76.0%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Linde India makes and supplies industrial and medical gases such as oxygen, nitrogen and argon, and builds air separation plants for customers, mainly in India.

Company snapshot

1stBy market cap

Ranked among 4 companies in Industrial Gases.

Segment mix

Reportable segments as of 2024-12-31 (Consolidated). Revenue share = segment revenue ÷ total revenue.

Largest segment: 83.9% of revenue

SegmentRevenue shareRevenuePBTAssets
Gases, related products & services
83.9%
508 Cr128 Cr3,463 Cr
Project engineering
43.4%
263 Cr36 Cr369 Cr
Share of profit from Joint Venture—0 Cr2 Cr0 Cr

Shares add up to 127% because segment revenues are before inter-segment eliminations.

What we see

Positives
  • ✓Net margin of 21.7% — the business keeps a healthy share of every rupee it earns.
1 more signal from the filings.Sign in free to see them all

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales711 Cr706 Cr630 Cr653 Cr634 Cr606 Cr592 Cr571 Cr644 Cr701 Cr614 Cr694 Cr
Operating expenses (approx.)538 Cr520 Cr452 Cr469 Cr456 Cr414 Cr382 Cr374 Cr362 Cr444 Cr441 Cr494 Cr
EBITDA174 Cr186 Cr179 Cr184 Cr179 Cr192 Cr210 Cr197 Cr282 Cr257 Cr173 Cr201 Cr
OPM %24.4%26.4%28.3%28.2%28.2%31.7%35.5%34.5%43.8%36.6%28.1%28.9%
Other income19 Cr22 Cr18 Cr19 Cr16 Cr19 Cr13 Cr4 Cr4 Cr4 Cr6 Cr6 Cr
Interest1 Cr1 Cr4 Cr2 Cr2 Cr2 Cr7 Cr3 Cr3 Cr6 Cr3 Cr6 Cr
Depreciation50 Cr51 Cr52 Cr51 Cr52 Cr55 Cr56 Cr56 Cr56 Cr62 Cr61 Cr62 Cr
Profit before tax143 Cr159 Cr142 Cr152 Cr143 Cr157 Cr161 Cr144 Cr228 Cr245 Cr116 Cr140 Cr
Tax %24.1%24.6%26.0%25.1%25.8%25.9%26.6%25.7%25.1%21.0%33.2%25.1%
Net profit109 Cr120 Cr105 Cr114 Cr106 Cr116 Cr118 Cr107 Cr171 Cr193 Cr77 Cr105 Cr
EPS (₹)₹12.75₹14.08₹12.36₹13.33₹12.48₹13.64₹13.88₹12.57₹20.05₹22.67₹9.08₹12.26

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricDec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Mar 2024Mar 2025Mar 2026TTM
Sales2,115 Cr2,192 Cr1,762 Cr1,471 Cr2,112 Cr2,505 Cr2,769 Cr2,485 Cr2,531 CrSign in free for the trailing twelve months
Operating expenses (approx.)1,787 Cr1,865 Cr1,345 Cr1,096 Cr1,565 Cr1,927 Cr2,066 Cr1,720 Cr1,622 CrSign in free for the trailing twelve months
EBITDA328 Cr326 Cr417 Cr375 Cr547 Cr578 Cr702 Cr765 Cr909 CrSign in free for the trailing twelve months
OPM %15.5%14.9%23.7%25.5%25.9%23.1%25.4%30.8%35.9%Sign in free for the trailing twelve months
Other income8 Cr8 Cr19 Cr33 Cr55 Cr82 Cr77 Cr68 Cr18 CrSign in free for the trailing twelve months
Interest116 Cr103 Cr86 Cr6 Cr3 Cr4 Cr7 Cr13 Cr14 CrSign in free for the trailing twelve months
Depreciation206 Cr199 Cr177 Cr176 Cr181 Cr187 Cr201 Cr214 Cr235 CrSign in free for the trailing twelve months
Profit before tax13 Cr39 Cr1,013 Cr229 Cr698 Cr477 Cr579 Cr614 Cr733 CrSign in free for the trailing twelve months
Tax %-20.8%34.8%28.2%33.9%27.3%8.1%25.0%25.9%25.2%Sign in free for the trailing twelve months
Net profit16 Cr26 Cr727 Cr151 Cr507 Cr439 Cr434 Cr455 Cr549 CrSign in free for the trailing twelve months
EPS (₹)₹1.90₹3.01₹85.27₹17.72₹59.47₹51.45₹50.90₹53.33₹64.37Sign in free for the trailing twelve months
Dividend payout %———56.4%5.0%26.2%23.5%22.4%18.6%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricDec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Mar 2024Mar 2025Mar 2026
Equity capital85 Cr85 Cr85 Cr85 Cr85 Cr85 Cr85 Cr85 Cr85 Cr
Reserves1,365 Cr1,377 Cr2,087 Cr2,149 Cr2,630 Cr2,955 Cr3,383 Cr3,735 Cr4,181 Cr
Borrowings926 Cr657 Cr8 Cr——————
Other liabilities1,032 Cr1,292 Cr1,070 Cr1,038 Cr1,302 Cr1,354 Cr1,337 Cr1,323 Cr1,542 Cr
Total liabilities3,409 Cr3,410 Cr3,250 Cr3,272 Cr4,017 Cr4,394 Cr4,805 Cr5,143 Cr5,808 Cr
Fixed assets (net)2,497 Cr2,161 Cr2,035 Cr1,989 Cr1,848 Cr1,769 Cr1,802 Cr1,906 Cr2,073 Cr
CWIP36 Cr44 Cr53 Cr17 Cr68 Cr186 Cr483 Cr975 Cr1,343 Cr
Investments58 Cr0.03 Cr0.03 Cr4 Cr9 Cr29 Cr50 Cr58 Cr82 Cr
Inventories68 Cr71 Cr65 Cr69 Cr69 Cr80 Cr85 Cr107 Cr123 Cr
Trade receivables353 Cr355 Cr383 Cr407 Cr396 Cr505 Cr481 Cr385 Cr508 Cr
Cash & bank38 Cr125 Cr240 Cr324 Cr983 Cr1,240 Cr979 Cr145 Cr110 Cr
Other assets359 Cr654 Cr474 Cr463 Cr643 Cr585 Cr925 Cr1,568 Cr1,569 Cr
Total assets3,409 Cr3,410 Cr3,250 Cr3,272 Cr4,017 Cr4,394 Cr4,805 Cr5,143 Cr5,808 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricDec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Mar 2024Mar 2025Mar 2026
Cash from operating activity252 Cr380 Cr327 Cr339 Cr589 Cr569 Cr437 Cr584 Cr786 Cr
Cash from investing-58 Cr-74 Cr981 Cr-54 Cr98 Cr-193 Cr-498 Cr-1,265 Cr-705 Cr
Cash from financing-261 Cr-220 Cr-1,193 Cr-201 Cr-28 Cr-118 Cr-146 Cr-152 Cr-116 Cr
Net cash flow-67 Cr87 Cr115 Cr84 Cr659 Cr257 Cr-208 Cr-833 Cr-35 Cr
Free cash flow (OCF − Capex)172 Cr286 Cr243 Cr269 Cr452 Cr557 Cr-135 Cr-747 Cr19 Cr

Ratios

MetricDec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Mar 2024Mar 2025Mar 2026
ROCE %5.5%6.7%50.4%10.5%25.8%15.8%16.9%16.4%17.5%
ROE %1.1%1.8%33.5%6.8%18.7%14.4%12.5%11.9%12.9%
Debtor days6159791016873635673
Inventory days1309378146644256162174
Days payable490415444962544335410823811
Cash conversion cycle-299-262-287-715-412-220-291-604-564
OCF / EBITDA %76.9%116.5%78.4%90.4%107.7%98.3%62.2%76.3%86.4%
OCF / EBITDA % (3 years)——89.6%93.6%93.7%99.8%——76.0%
Debt / equity0.640.450.0039——————
Current ratio0.660.561.151.472.112.091.870.950.86
Net debt / EBITDA2.711.63-0.56-0.86-1.80-2.14-1.39-0.19-0.12